Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
<br/><strong>Introduction: </strong>RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass RTS,S/AS0...
Main Authors: | Von Seidlein, L, Hanboonkunupakarn, B, Jittamala, P, Pongsuwan, P, Chotivanich, K, Tarning, J, Hoglund, R, Winterberg, M, Mukaka, M, Peerawaranun, P, Sirithiranont, P, Doran, Z, Ockenhouse, C, Ivinson, K, Lee, C, Birkett, A, Kaslow, D, Singhasivanon, P, Day, N, Dondorp, A, White, N, Pukrittayakamee, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Taylor and Francis
2019
|
Similar Items
-
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
by: Lorenz von Seidlein, et al.
Published: (2020-01-01) -
Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects
by: Kobylinski, KC, et al.
Published: (2019) -
Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults
by: Hanboonkunupakarn, B, et al.
Published: (2019) -
Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
by: Hanboonkunupakarn, B, et al.
Published: (2014) -
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
by: Chotsiri, P, et al.
Published: (2017)